Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects.

Human psychopharmacology - 1 Mar 2008

Saiz Pilar A, Susce Margaret T, Clark Dan A, Kerwin Robert W, Molero Patricio, Arranz Maria J, de Leon Jose

Abstract excerpt

Antipsychotic treatment is hampered by the induction of side-effects such as tardive dyskinesia (TD), weight gain, sedation and extrapyramidal side-effects (EPS). Identification of the factors related to their development would facilitate their avoidance and the improvement of antipsychotic treatment. It has been hypothesised that genetic variants in drug targeted receptors may contribute to the development of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyskinesia, Drug-Induced

Share to Genotype

Share to Obesity

Share to Polymorphism, Single Nucleotide

Share to Receptors, Adrenergic, alpha-1

Share to White People

Source

Identifiers

PMID: 17972277
DOI: 10.1002/hup.903

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects.PMID 17972277Read ↗

The pharmacogenetics of antipsychotic-induced adverse events.Semantic proximity Read ↗

Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain.Semantic proximity Read ↗

Association of the α2A Adrenergic Receptor -1291C/G Polymorphism and Antipsychotic-Induced Weight Gain in European–AmericansSemantic proximity Read ↗

Association between the 1291-C/G polymorphism in the adrenergic α-2a receptor and the metabolic syndrome.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced side effects.Semantic proximity Read ↗

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic DrugsSemantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced side effectsSemantic proximity Read ↗

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.Semantic proximity Read ↗

Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment.Semantic proximity Read ↗

No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Semantic proximity Read ↗

Polymorphism of the adrenergic receptor alpha 2a -1291C>G genetic variation and clozapine-induced weight gain.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.